Study Of Boston Scientific's Carotid WALLSTENT™ Monorail™ Design Shows Superior Safety Results In Stroke Prevention
Wed, 21 Jun 2006 06:00 AM EST
... Boston Scientific Corporation (NYSE: BSX) today welcomed the results of a new study, led by Dr. Marc Bosiers of Belgium, demonstrating that the closed cell design of Boston Scientific's Carotid WALLSTENT™ Monorail™ provides superior clinical outcomes compared to open cell carotid stents. [click link for full article] ...

Not Signed In -


